Cargando…

The integration of HR-HPV increases the expression of cyclins A and E in cytologies with and without low-grade lesions

BACKGROUND: Cyclin-A and cyclin-E are regulators of G1–S phase of normal cell cycle. Integration of human papilloma virus high-risk (HR-HPV) could alter this mechanism, and its overexpression has been associated with poor prognosis in cervical cancer. AIM: To determine the expression of cyclin-A and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zubillaga-Guerrero, MI, Illades-Aguiar, B, Leyva-Vazquez, MA, Flores-Alfaro, E, Castañeda-Saucedo, E, Muñoz-Valle, JF, Alarcón-Romero, LC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643354/ https://www.ncbi.nlm.nih.gov/pubmed/23661932 http://dx.doi.org/10.4103/0970-9371.107504

Ejemplares similares

An increase of microRNA-16-1 is associated with the high proliferation of squamous intraepithelial lesions in the presence of the integrated state of HR-HPV in liquid cytology samples
por: Zubillaga-Guerrero, Ma Isabel, et al.
Publicado: (2020)

Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
por: Vega-Peña, Arianna, et al.
Publicado: (2013)

TOP2A/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions
por: Del Moral-Hernández, Oscar, et al.
Publicado: (2021)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

Use of extended HR-HPV Genotyping in improving the Triage Strategy of 2019 ASCCP recommendations in Women with positive HR-HPV diagnosis and Simultaneous LSIL Cytology Results
por: Xue, Huifeng, et al.
Publicado: (2021)

Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing
por: Kocken, M, et al.
Publicado: (2012)

HPV molecular detection from urine versus cervical samples: an alternative for HPV screening in indigenous populations
por: Torres-Rojas, Francisco I., et al.
Publicado: (2021)

Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer
por: Zacapala-Gómez, Ana E., et al.
Publicado: (2018)

Investigation of the Clinical Application Value of HR-HPV DNA Combined with Liquid Based Cytology in Colposcopy of Cervical Cancer
por: Zhou, Ying
Publicado: (2022)

Modeling and Molecular Dynamics of the 3D Structure of the HPV16 E7 Protein and Its Variants
por: Bello-Rios, Ciresthel, et al.
Publicado: (2021)

In silico prediction of structural changes in human papillomavirus type 16 (HPV16) E6 oncoprotein and its variants
por: Rodríguez-Ruiz, Hugo Alberto, et al.
Publicado: (2019)

Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain
por: Araujo-Arcos, Lilian Esmeralda, et al.
Publicado: (2022)

Retracted: Investigation of the Clinical Application Value of HR-HPV DNA Combined with Liquid Based Cytology in Colposcopy of Cervical Cancer
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Differential proteins among normal cervix cells and cervical cancer cells with HPV-16 infection, through mass spectrometry-based Proteomics (2D-DIGE) in women from Southern México
por: Serafín-Higuera, Idanya, et al.
Publicado: (2016)

Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions
por: Torres-Rojas, Francisco Israel, et al.
Publicado: (2018)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Triage of HR-HPV Positive Women with Minor Cytological Abnormalities: A Comparison of mRNA Testing, HPV DNA Testing, and Repeat Cytology Using a 4-Year Follow-Up of a Population-Based Study
por: Persson, Maria, et al.
Publicado: (2014)

HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study
por: Andersen, Berit, et al.
Publicado: (2020)

Cytokine Release in HR-HPV(+) Women without and with Cervical Dysplasia (CIN II and III) or Carcinoma, Compared with HR-HPV([Formula: see text]) Controls
por: Bais, Aagje G., et al.
Publicado: (2007)

Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
por: Brismar-Wendel, S, et al.
Publicado: (2009)

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening
por: Harper, Diane M., et al.
Publicado: (2023)

Prevalence and risk factors for High-Risk Human Papillomavirus (hrHPV) infection among HIV-infected and Uninfected Rwandan women: implications for hrHPV-based screening in Rwanda
por: Sinayobye, Jean d’Amour, et al.
Publicado: (2014)

Expression of HIF-1α and Genes Involved in Glucose Metabolism Is Increased in Cervical Cancer and HPV-16-Positive Cell Lines
por: Priego-Hernández, Víctor D., et al.
Publicado: (2022)

Significant decrease of a master regulator of genes (REST/NRSF) in high-grade squamous intraepithelial lesion and cervical cancer
por: Cortés-Sarabia, Karen, et al.
Publicado: (2021)

High prevalence of HPV16 and high‐grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2
por: Damgaard, Rikke Kamp, et al.
Publicado: (2023)

Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
por: Rodríguez-Nava, Cynthia, et al.
Publicado: (2023)

The CpG island methylator phenotype increases the risk of high-grade squamous intraepithelial lesions and cervical cancer
por: Loaeza-Loaeza, Jaqueline, et al.
Publicado: (2022)

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial
por: Sargent, A, et al.
Publicado: (2008)

Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2011)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM
por: Hidalgo-Tenorio, Carmen, et al.
Publicado: (2019)

hrHPV E5 oncoprotein: immune evasion and related immunotherapies
por: de Freitas, Antonio Carlos, et al.
Publicado: (2017)

Determination and evaluation of HR-HPV genotype in different communities of Bihar, India
por: Parwez, Akhtar, et al.
Publicado: (2022)

Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
por: Molina, Mariano A., et al.
Publicado: (2023)

Impact of HR-HPV infection on oncological outcomes in early cervical cancer
por: Su, Xiaoqiang, et al.
Publicado: (2023)

Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children
por: De la Cruz-Mosso, Ulises, et al.
Publicado: (2012)

Nuclear expression of Rac1 in cervical premalignant lesions and cervical cancer cells
por: Mendoza-Catalán, Miguel A, et al.
Publicado: (2012)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fv44uii1jr197b90595k8djnhe